Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLE for Food Intolerance in IBS: Stress Control Group
NCT02316132Withdrawn
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Dec 2014
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Universitätsklinikum Schleswig-Holstein. Primary endpoint: Visible marked increase of leaks/gaps with extrusion of fluorescein into the gut lumen. Planned start Dec 2014; status: withdrawn.
Beyond the preview
Go deeper on NCT02316132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02316132.